logo

For the Inventor, By the Inventor

Buffalo Grove, IL, United States of America

Esam Z Dajani

This inventor holds 8 USPTO granted patents. Top assignees: G.d. Searle & Company, Cv Therapeutics, Inc.. Active years: 1976-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esam Z Dajani. Retrieved from https://idiyas.com/inventor/esam-z-dajani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 126(Granted Patents)


Location History:

  • Buffalo Grove, IL (US) (1976 - 1978)
  • Long Grove, IL (US) (1984 - 1997)

Company Filing History:

goldMedal7 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal1 out of 105 
 
Cv Therapeutics, Inc.
 patents

Years Active: 1976-1997

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5679375 - Method of treating ulcers with sulfated polysaccharides (1997-10-21),
2. 4459310 - Method for cholesterol lowering (1984-07-10),
3. 4086227 - Novel anti-diarrheal 4-azatricyclo[4.3.1.1.sup.3,8 ] undecane derivatives (1978-04-25),
4. 4072686 - 1-(3,3,3-Triarylalkyl)-4-phenyl-piperidinealkanols (1978-02-07),
5. 4066654 - 1-Triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives (1978-01-03),
6. 4057549 - Triarylpropyl-azabicyclooctanes (1977-11-08),
7. 3998832 - Anti-diarrheal compounds (1976-12-21),
8. 3996214 - 5-(1,1-Diphenyl-4-(cyclic amino) (1976-12-07),

Title: The Innovative Contributions of Esam Z Dajani

Introduction

Esam Z Dajani is a notable inventor based in Buffalo Grove, Illinois, recognized for his significant contributions to medical and pharmaceutical innovations. With a portfolio of eight patents, Dajani has focused primarily on advancements aimed at improving healthcare outcomes through his inventive methods.

Latest Patents

Among his latest inventions is a method for treating ulcers using sulfated polysaccharides. This innovative approach involves the administration of purified, high molecular weight sulfated polysaccharide compositions to inhibit and treat gastric and duodenal ulcers effectively. Furthermore, Dajani has developed a method for lowering cholesterol that utilizes 16-loweralkyl-16-hydroxy prostaglandins, such as misoprostol. This class of prostaglandins has demonstrated efficacy in reducing cholesterol levels in patients suffering from hypercholesterolemia.

Career Highlights

Throughout his career, Esam Z Dajani has collaborated with prominent organizations, notably G.D. Searle & Company and C.V. Therapeutics. These positions have allowed him to refine his expertise and contribute to impactful healthcare solutions.

Collaborations

Dajani has also worked alongside distinguished colleagues, including Chung H. Yen and Gilbert W. Adelstein. These partnerships have played an integral role in advancing his research and fostering innovation in the field.

Conclusion

Esam Z Dajani's contributions to the field of medicine illustrate the importance of innovative thinking in addressing health-related challenges. His work continues to pave the way for developments that may enhance patient care and improve the overall quality of life.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…